首页> 外文期刊>Biopreservation and biobanking >Evaluation of the Analytical and Clinical Concordance of 25-Hydroxyvitamin D Levels in Dried Blood Spots, Dried Serum Spots, and Serum as Potential Biorepository Specimens
【24h】

Evaluation of the Analytical and Clinical Concordance of 25-Hydroxyvitamin D Levels in Dried Blood Spots, Dried Serum Spots, and Serum as Potential Biorepository Specimens

机译:将25-羟基vitamind水平的分析和临床协调评价干燥血斑,干燥血清斑点和血清作为潜在的生物宿园样本

获取原文
获取原文并翻译 | 示例
           

摘要

Context: The promising perspective of storing dried blood spot (DBS) for evaluating 25-hydroxyvitamin D (25OHD) levels is increasingly being realized. While strong correlations have been demonstrated between 25OHD levels measured in DBS and in systemic serum samples in earlier works, the clinical concordance of the assay results has not been evaluated. Moreover, the utility of dried serum spot (DSS), a highly suitable matrix for sample archiving, has not been investigated in this respect. Methods: 25-hydroxycholecalciferol and 25-hydroxyergocalciferol levels were established selectively in DBS (n=73) and DSS (n=67) specimens obtained from deidentified whole blood and serum using a previously validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In addition, total 25OHD levels were determined in the serum samples using the LIAISON 25OH Total Vitamin D Assay (LIA, n=73). The analytical and clinical performance of the three approaches was compared pairwise. Results: Deming regression, Bland-Altman analysis, and concordance correlation coefficients consistently demonstrated the lack of analytical equivalence among the three result sets. The overall percentage agreement of the clinical classifications (hypovitaminosis or euvitaminosis) was moderate (67.1%-83.6%). The delivery of positive cases was decreasing significantly in the order LIA>DSS>DBS (p<0.05). Conclusions: The approaches tested did not deliver equivalent outputs either in an analytical or a clinical context. Therefore, specific reference ranges must be established for each matrix to avoid false clinical evaluation. 25OHD can be quantified when assay results are scaled by a factor of 1.60-1.67. Considering the convenience and efficiency of the storage and processing of DSS, along with the difficulties of quantifying 25OHD in real-life DBS samples accurately, DSS is proposed as an alternative for the long-term archiving of specimens.
机译:背景:越来越多地实现将用于评估25-羟基苯胺D(25Ohd)水平的干血斑(DBS)的有前途的观点。虽然在DBS中测量的25Ohd水平和早期作品中的全身性血清样品中已经证明了强的相关性,但尚未评估测定结果的临床一致性。此外,在这方面,尚未研究干燥的血清点(DSS),对样品归档的高度合适基质的效用。方法:使用先前验证的液相色谱 - 串联质谱法(LC-MS / MS)方法。此外,使用联络25OH总维生素D测定法(LIA,N = 73),在血清样品中测定总250多水平。比较三种方法的分析和临床表现。结果:拆除回归,Bland-Altman分析和一致性相关系数始终如一地证明了三个结果集之间的分析等效。临床分类的总体百分比协议(下钙胺胺病或欧凡氨酸)中度(67.1%-83.6%)。阳性病例的递送在LIA> DSS> DBS中有显着递减(P <0.05)。结论:测试的方法未在分析或临床环境中提供等效产出。因此,必须为每个矩阵建立特定的参考范围以避免错误的临床评估。当测定结果缩小为1.60-1.67时,可以量化25Ohd。考虑到DSS的储存和处理的便利性和效率,以及准确地定量25Ohd的困难,提出了DSS作为标本长期归档的替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号